Henan Taloph Pharmaceutical Stock Co (SHSE:600222) EV-to-EBIT : 51.06 (As of Jun. 16, 2024)

Henan Taloph Pharmaceutical Stock Co EV-to-EBIT Chart

Henan Taloph Pharmaceutical Stock Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					68.60	35.59	439.13	-50.40	89.40

Henan Taloph Pharmaceutical Stock Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-45.35	-36.48	-75.03	89.40	60.44

Competitive Comparison of Henan Taloph Pharmaceutical Stock Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Henan Taloph Pharmaceutical Stock Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's EV-to-EBIT falls into.

Henan Taloph Pharmaceutical Stock Co EV-to-EBIT Calculation

Henan Taloph Pharmaceutical Stock Co's EV-to-EBIT for today is calculated as:

Henan Taloph Pharmaceutical Stock Co's current Enterprise Value is ¥3,040 Mil.
Henan Taloph Pharmaceutical Stock Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Taloph Pharmaceutical Stock Co  (SHSE:600222) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Henan Taloph Pharmaceutical Stock Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Henan Taloph Pharmaceutical Stock Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥3,599 Mil.
Henan Taloph Pharmaceutical Stock Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Taloph Pharmaceutical Stock Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Business Description